Microbial Influences in Inflammatory Bowel Diseases

Slides:



Advertisements
Similar presentations
Musketeers Course October The Mucosal Immune System The organization of the mucosal immune systemThe organization of the mucosal immune system The.
Advertisements

Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
Pattern recognition receptors (PRRs)
The innate immune response
INNATE IMMUNITY/ MUCOSAL IMMUNOLOGY REVIEW
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Experimental Models of Inflammatory Bowel Diseases
Innate Immune Response (Ch14)
Volume 31, Issue 3, Pages (September 2009)
Acute Graft-versus-Host Disease: Novel Biological Insights
Chapter 5 Innate Immunity Dr. Capers
Inflammation and Colon Cancer
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Immune Responses to the Microbiota at the Intestinal Mucosal Surface
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Gut Microbiota: Mining for Therapeutic Potential
Microbial Symbiosis with the Innate Immune Defense System of the Skin
Tumor necrosis factor: Biology and therapeutic inhibitors
Daniel A. Peterson, Daniel N. Frank, Norman R. Pace, Jeffrey I. Gordon 
Roles for Chemokines in Liver Disease
Gut–liver immunity Journal of Hepatology
The Gastrointestinal Tract and AIDS Pathogenesis
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
R. Balfour Sartor, MD  Clinical Gastroenterology and Hepatology 
Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights
Intestinal Permeability Defects: Is It Time to Treat?
The Intestinal Immune System in Obesity and Insulin Resistance
Autophagy and senescence in fibrosing cholangiopathies
Volume 139, Issue 6, Pages (December 2010)
Jo-Ellen Murphy, Caroline Robert, Thomas S. Kupper 
Kara Gross Margolis, Charalabos Pothoulakis  Gastroenterology 
Microbes in Gastrointestinal Health and Disease
Inflammatory health effects of indoor and outdoor particulate matter
Celiac Disease: From Pathogenesis to Novel Therapies
The Origins and Drivers of Insulin Resistance
John T. Chang, William J. Sandborn  Gastroenterology 
Autophagy, Microbial Sensing, Endoplasmic Reticulum Stress, and Epithelial Function in Inflammatory Bowel Disease  Arthur Kaser, Richard S. Blumberg 
Bridging immunity and lipid metabolism by gut microbiota
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Mechanisms of Disease: Inflammatory Bowel Diseases
Innate sensors of pathogen and stress: Linking inflammation to obesity
Maya Saleh, Charles O. Elson  Immunity 
Volume 146, Issue 4, Pages e1 (April 2014)
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Hans-Joachim Anders, Kirstin Andersen, Bärbel Stecher 
Role of the Microbiota in Immunity and Inflammation
Translating Inflammatory Bowel Disease Research into Clinical Medicine
The Role of TIM-4 in Food Allergy
Inflammasomes in Intestinal Inflammation and Cancer
Overview of structural and functional mechanisms by which enterovirulent bacteria cause diarrhea. Overview of structural and functional mechanisms by which.
Drivers of chronic rhinosinusitis: Inflammation versus infection
Homeostasis and Inflammation in the Intestine
Volume 141, Issue 1, Pages (July 2011)
The gastrointestinal mucosa in health, CDI, and UC
Daniel A. Peterson, Daniel N. Frank, Norman R. Pace, Jeffrey I. Gordon 
Norovirus Regulation by Host and Microbe
Brian K. Coombes, Yanet Valdez, B.Brett Finlay  Current Biology 
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Mechanisms of food allergy
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
The Biology of Intestinal Immunoglobulin A Responses
Learning Tolerance while Fighting Ignorance
Events modulating E. coli colonization and fitness in the intestine.
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases  Louis J. Cohen, Judy H. Cho,
Volume 31, Issue 3, Pages (September 2009)
Tumor necrosis factor: Biology and therapeutic inhibitors
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
The Tuning of the Gut Nervous System by Commensal Microbiota
Presentation transcript:

Microbial Influences in Inflammatory Bowel Diseases R. Balfour Sartor  Gastroenterology  Volume 134, Issue 2, Pages 577-594 (February 2008) DOI: 10.1053/j.gastro.2007.11.059 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Composition and luminal concentrations of dominant microbial species in various regions of the gastrointestinal tract. Gastroenterology 2008 134, 577-594DOI: (10.1053/j.gastro.2007.11.059) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Recognition of bacterial ligands by membrane-bound toll-like receptors (TLR) and nod-like receptors (NLR), with signaling through conserved pathways such as NF-κB and mitogen-activated protein kinases (MAPK) signal transduction pathways. Gastroenterology 2008 134, 577-594DOI: (10.1053/j.gastro.2007.11.059) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Potential mechanisms by which enteric bacteria and fungi induce chronic immune-mediated intestinal injury. (A) Pathogenic bacteria. A traditional pathogen or functional alterations in commensal bacteria (increased epithelial adherence, invasion, resistance to killing) can lead to increased bacterial stimulation of innate and adaptive immune responses. (B) Abnormal microbial composition. Decreased concentrations of protective bacteria that produce SCFA such as butyrate can enhance mucosal permeability. Conversely, increased concentrations of aggressive bacteria increase the amount of adjuvants and antigens that induce pathogenic immune responses or increase production of toxic metabolites such as hydrogen sulfide (H2S) that increase mucosal permeability and block butyrate metabolism. (C) Defective host containment of commensal bacteria. Defective secretion of antimicrobial peptides or secretory IgA can lead to mucosal bacterial overgrowth, whereas defective killing of phagocytosed bacteria can lead to persistent intracellular bacteria and ineffective clearance of bacterial antigens. Increased mucosal permeability can result in overwhelming exposure of bacterial TLR ligands and antigens that activate pathogenic innate and T-cell immune responses. (D) Defective host immunoregulation. Ineffective down-regulation of innate immune responses, either in epithelial or antigen-presenting cells (APC), can induce inflammatory responses through secretion of chemokines or proinflammatory cytokines. Dysfunction of regulatory T cells or APC can lead to overly aggressive T responses (loss of tolerance) to ubiquitous microbial antigens or induction of cross-reactive autoimmune responses because of molecular mimicry between host and microbial antigens. Gastroenterology 2008 134, 577-594DOI: (10.1053/j.gastro.2007.11.059) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 Pathogenesis of epithelial attachment and tissue injury with adherent/invasive E coli (AIEC). AIEC induce carcinoembryonic antigen cell adhesion molecule (CEACAM) 6, either directly or by stimulating production of TNF and interferon γ (IFNγ), and attach, invade, and stimulate macrophages and T cells in the lamina propria. Modified from Abraham C and Cho J, N Engl J Med 2007;357:708–710. Gastroenterology 2008 134, 577-594DOI: (10.1053/j.gastro.2007.11.059) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 Contrast of bacterial/epithelial and epithelial/immune interactions in mucosal homeostasis vs IBD. (A) The normal intestine has limited, controlled uptake of microbial antigens; exclusion of viable organisms; a state of nonresponsiveness of epithelial, innate, and adaptive immune cells; and secretion of IL-10 and TGF-β. (B) In IBD, functionally abnormal bacteria attach to and invade epithelial cells in the absence of secreted antimicrobial peptides (defensins) and persist within epithelial cells and phagocytic cells if intracellular killing is defective. Stimulation of Th1/Th17 cells by persistent secretion of IL-12, IL-23, IL-6, and TNF leads to chronic tissue injury and epithelial damage, which is perpetuated by ongoing translocation of enteric bacteria, microbial antigens, and TLR ligands. Gastroenterology 2008 134, 577-594DOI: (10.1053/j.gastro.2007.11.059) Copyright © 2008 AGA Institute Terms and Conditions